New-onset diabetes in treated hypertensive patients

被引:29
|
作者
Verdecchia, P [1 ]
Angeli, F [1 ]
Reboldi, GP [1 ]
Gattobigio, R [1 ]
机构
[1] Osped R Silvestrini, Dipartimento Malattie Cardiovasc, I-06100 Perugia, Italy
关键词
D O I
10.1007/s11906-005-0006-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Interpretation of some recent trials in hypertension opened a debate on the clinical value of new-onset diabetes in treated hypertensive patients. It is not completely clear whether certain anti hypertensive drug classes are associated with a higher risk for developing type 2 diabetes when compared with other classes. Some longitudinal studies suggest that new-onset diabetes in treated hypertensive subjects carries a risk for subsequent cardiovascular disease similar to that of previously known diabetes. In a study, plasma glucose before treatment and diuretic treatment were independent predictors of new-onset diabetes in hypertensive patients, independent of confounding factors. We estimated that one cardiovascular event associated with new-onset diabetes might be prevented for every 385 to 449 patients treated with "new," rather than "old," anti hypertensive drugs for approximately 4 years. These observations suggest that concern about the risk for new-onset diabetes should prompt a more judicious use of diuretics and beta-blockers in the treatment of hypertension. These drugs should be given cautiously in subjects who are at increased risk for new-onset diabetes, owing to impaired fasting glucose or obesity. The lowest effective dose should be used, and plasma glucose should be carefully monitored.
引用
收藏
页码:174 / 179
页数:6
相关论文
共 50 条
  • [1] New-onset diabetes in treated hypertensive patients
    Paolo Verdecchia
    Fabio Angeli
    Gian Paolo Reboldi
    Roberto Gattobigio
    [J]. Current Hypertension Reports, 2005, 7 : 174 - 179
  • [2] New-onset diabetes in hypertensive patients and mortality: timing is everything
    Bruno, Rosa Maria
    Taddei, Stefano
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (12) : 975 - 977
  • [3] Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes
    Lip, Stefanie
    Jeemon, Panniyammakal
    McCallum, Linsay
    Dominiczak, Anna F.
    McInnes, Gordon T.
    Padmanabhan, Sandosh
    [J]. EUROPEAN HEART JOURNAL, 2016, 37 (12) : 968 - 974
  • [4] New-onset diabetes and anti hypertensive drugs
    Mancia, G
    Grassi, G
    Zanchetti, A
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 (01) : 3 - 10
  • [5] Preventing new-onset diabetes in thiazide-treated patients
    Mancia, Giuseppe
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (02): : 90 - 92
  • [6] Is serum uric acid a predictor of new-onset diabetes in hypertensive patients?
    Jong, Gwo-Ping
    Ma, Tsochiang
    [J]. THROMBOSIS RESEARCH, 2012, 130 : S134 - S134
  • [7] Association between pulse pressure and new-onset diabetes in hypertensive patients
    李尉键
    [J]. China Medical Abstracts (Internal Medicine), 2021, (04) : 210 - 211
  • [8] Predictors of new-onset diabetes mellitus in hypertensive patients:: the VALUE trial
    Aksnes, T. A.
    Kjeldsen, S. E.
    Rostrup, M.
    Stoerset, O.
    Hua, T. A.
    Julius, S.
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2008, 22 (08) : 520 - 527
  • [9] Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial
    T A Aksnes
    S E Kjeldsen
    M Rostrup
    Ö Störset
    T A Hua
    S Julius
    [J]. Journal of Human Hypertension, 2008, 22 : 520 - 527
  • [10] Diabetes and New-Onset Atrial Fibrillation in a Hypertensive Population
    Alves-Cabratosa, Lia
    Garcia-Gil, Maria
    Comas-Cufi, Marc
    Marti, Ruth
    Ponjoan, Anna
    Parramon, Didac
    Blanch, Jordi
    Ramos, Rafel
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 90 - 91